As winter 2022 comes to a close, the Hackensack Meridian Neuroscience Institute team is reflecting on the past year’s opportunities, innovations, and accomplishments and looking forward to an exciting, bright future.
In 2021, Hackensack Meridian Health made significant investments in its three Neuroscience Institutes, expanding programs and services at its three academic hubs: Hackensack University Medical Center, JFK University Medical Center and Jersey Shore University Medical Center. Among our most significant investments was the recruitment of clinicians whose expertise, training, experience and professionalism will create a multidisciplinary team equipped to provide life-enhancing — and often life-saving — care to patients across all of New Jersey.
Similarly, our research and technology are advancing our understanding and treatment of ALS, stroke, epilepsy, Alzheimer’s disease, concussion, tremors, brain tumors, Charcot-Marie-Tooth (CMT) neuropathies and other neurological conditions.
By enhancing the strength of our Neuroscience Institute across our entire health network, we will be able to continue attracting clinicians, research opportunities, and programs that help us deliver on our mission of providing outstanding neurological care and advancing the field of neuroscience.
